admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for...

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023

BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare...

Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching...

Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical...

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human...

Psychedelics Weekly – The Church of Psilomethoxin Controversy, Psychedelics for Long...

Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related...

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Bright Minds Biosciences Receives a Favorable Written Opinion from the International...

1...717273...218 Page 72 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin